Biotrend Cevre ve Enerji Yatirimlari A.S. (IST:BIOEN)
Turkey · Delayed Price · Currency is TRY 19.98
+0.75 (3.90%)
At close: Feb 9, 2026
IST:BIOEN Income Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 2,233 | 2,688 | 3,224 | 2,338 | 427.7 | 245.3 | |
Revenue Growth (YoY) | -35.89% | -16.64% | 37.91% | 446.57% | 74.36% | 166.47% |
Operations & Maintenance | 47.45 | 52.62 | 69.5 | 50.97 | 10.27 | 6.77 |
Selling, General & Admin | 427.15 | 478.59 | 456.4 | 249.27 | 42.47 | 21.94 |
Other Operating Expenses | 2,144 | 2,524 | 2,638 | 1,486 | 286.45 | 173.43 |
Total Operating Expenses | 2,618 | 3,055 | 3,164 | 1,787 | 339.19 | 202.14 |
Operating Income | -385.19 | -367.39 | 59.72 | 551.03 | 88.51 | 43.16 |
Interest Expense | -328.82 | -460.86 | -441.46 | -106.86 | -31.55 | -14.16 |
Interest Income | -27.49 | 279.29 | 123.46 | 15.9 | 25.71 | 28.47 |
Net Interest Expense | -356.31 | -181.57 | -318 | -90.96 | -5.84 | 14.31 |
Income (Loss) on Equity Investments | -49.87 | -104.61 | 142.18 | 41.05 | 25.74 | 11.14 |
Currency Exchange Gain (Loss) | -857.35 | -459.63 | 109.91 | -272.02 | -77.32 | -1.16 |
Other Non-Operating Income (Expenses) | 817.74 | 1,252 | 1,361 | 463.03 | -2.46 | -3.11 |
EBT Excluding Unusual Items | -830.97 | 138.66 | 1,355 | 692.13 | 28.64 | 64.35 |
Gain (Loss) on Sale of Investments | -1.01 | -0.02 | -12.15 | - | - | -0.68 |
Legal Settlements | 5.28 | -1.35 | -2.6 | -6.85 | -5.22 | -4.24 |
Pretax Income | -826.7 | 137.29 | 1,340 | 685.28 | 23.42 | 59.42 |
Income Tax Expense | -47.2 | 38.7 | -31.79 | 108.73 | 19.43 | 9.5 |
Earnings From Continuing Ops. | -779.5 | 98.6 | 1,372 | 576.56 | 4 | 49.92 |
Minority Interest in Earnings | -5.22 | - | -2.87 | 0.2 | 2.55 | 0.55 |
Net Income | -784.72 | 98.6 | 1,369 | 576.76 | 6.54 | 50.47 |
Net Income to Common | -784.72 | 98.6 | 1,369 | 576.76 | 6.54 | 50.47 |
Net Income Growth | - | -92.80% | 137.34% | 8716.24% | -87.04% | 788.28% |
Shares Outstanding (Basic) | 500 | 500 | 500 | 500 | 500 | 427 |
Shares Outstanding (Diluted) | 500 | 500 | 500 | 500 | 500 | 427 |
Shares Change (YoY) | - | - | - | - | 17.19% | 11030.44% |
EPS (Basic) | -1.57 | 0.20 | 2.74 | 1.15 | 0.01 | 0.12 |
EPS (Diluted) | -1.57 | 0.20 | 2.74 | 1.15 | 0.01 | 0.12 |
EPS Growth | - | -92.80% | 137.34% | 8716.25% | -88.94% | -92.02% |
Free Cash Flow | 1,048 | 631.73 | 100.46 | -354.09 | -767.25 | -234.14 |
Free Cash Flow Per Share | 2.10 | 1.26 | 0.20 | -0.71 | -1.53 | -0.55 |
Profit Margin | -35.14% | 3.67% | 42.46% | 24.67% | 1.53% | 20.58% |
Free Cash Flow Margin | 46.91% | 23.51% | 3.12% | -15.15% | -179.39% | -95.45% |
EBITDA | 238.83 | 251.77 | 617.65 | 831.54 | 119.87 | 64.59 |
EBITDA Margin | 10.70% | 9.37% | 19.16% | 35.57% | 28.03% | 26.33% |
D&A For EBITDA | 624.02 | 619.17 | 557.93 | 280.5 | 31.35 | 21.43 |
EBIT | -385.19 | -367.39 | 59.72 | 551.03 | 88.51 | 43.16 |
EBIT Margin | -17.25% | -13.67% | 1.85% | 23.57% | 20.70% | 17.60% |
Effective Tax Rate | - | 28.18% | - | 15.87% | 82.94% | 15.98% |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.